Mon, May 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 4, 2024
[ 12:00 AM ] - WOPRAI
Mon, February 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, January 17, 2024
[ 12:00 AM ] - WOPRAI
Tue, November 7, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 10, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 19, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 2, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 16, 2022
[ 12:00 AM ] - WOPRAI
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
Mon, August 8, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 2, 2022
[ 12:00 AM ] - WOPRAI
Thu, July 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 19, 2022
[ 12:00 AM ] - WOPRAI
Thu, May 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 21, 2022
[ 12:00 AM ] - WOPRAI
Mon, March 7, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 1, 2022
[ 12:00 AM ] - WOPRAI
Tue, December 14, 2021
[ 12:00 AM ] - WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $30 on, May 6th, 2024
Nathan Rich of Goldman Sachs, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Decreased Target from $34 to $30 on, May 6th, 2024.
Nathan has made no other calls on XRAY in the last 4 months.
There are 6 other peers that have a rating on XRAY. Out of the 6 peers that are also analyzing XRAY, 2 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jason Bednar of "Piper Sandler" Reiterated at Hold with Decreased Target to $32 on, Friday, May 3rd, 2024
- Jeffrey Johnson of "Baird" Maintained at Hold with Decreased Target to $33 on, Friday, May 3rd, 2024
These are the ratings of the 4 analyists that currently disagree with Nathan
- David Saxon of "Needham" Maintained at Strong Buy with Decreased Target to $36 on, Friday, May 3rd, 2024
- Elizabeth Anderson of "Evercore ISI Group" Maintained at Buy with Decreased Target to $35 on, Friday, May 3rd, 2024
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $38 on, Friday, May 3rd, 2024
- Michael Cherny of "Leerink Partners" Initiated at Buy and Held Target at $42 on, Monday, February 26th, 2024
Contributing Sources